Drug Database
Back to search

Norway· NO-ID_6DC557E8-59E5-4A05-83F2-7F4D3F25AC11

Aminophylline hameln

A aminophylline product containing teofyllinetylendiamin, registered in Norway by Hameln Pharma Plus GmbH. The same ATC class is registered in 11 of our 19 countries.

ATC R03DA05

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedAminophylline hamelnATCR03DA05REGISTER NO.NO-ID_6DC557E8-59E5-4…PACKS LISTED2CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about teofyllinetylendiaminAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Aminophylline is registered in 11 of 19 countries.

Countries holding a registration under ATC R03DA05 (aminophylline), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 7 of them publish a price we can compare per daily dose
Search aminophylline products by name

Aminophylline · ATC R03DA05

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Ireland
  • Japan
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Teofyllinetylendiamin
Manufacturer
Hameln Pharma Plus GmbH
Country
Norway (NO)
ATC code
R03DA05
ATC class
Aminophylline
Defined daily dose
0.6 g, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 2

  • no_merkevare_id
    ID_6DC557E8-59E5-4A05-83F2-7F4D3F25AC11
  • no_varenummer
    270745
    10 x 10

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

323 interactions on record for aminophylline.

Graded by severity as the source publishes them — 34 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check aminophylline against other medicinesHow interaction checks work

Aminophylline · interactions on record

323 records

  • 34 severe
  • 174 moderate
  • 38 minor
  • 76 info

Most severe, free to view

  • MexiletineC01BB02severe
  • RiociguatC02KX05severe
  • PindololC07AA03severe
  • PropranololC07AA05severe

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Aminophylline in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All aminophylline products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Bulgaria · Софафилин
  • Czechia · Syntophyllin
  • Finland · Aminocont
  • France · Aminophylline Renaudin
  • United Kingdom (Northern Ireland) · Aminophylline N.A., Phyllocontin
  • Greece · Aminophylline Cooper, Αμινοφυλλινη Demo
  • Croatia · Brolyfin
  • Hungary · Diaphyllin Venosum
  • Ireland · Aminophylline Hydrate Mercury Pharmaceuticals (Ireland) Ltd, Phyllocontin
  • Italy · Aminofillina Galenica Senese, Aminofillina Monico
  • Lithuania · Aminophylline Sopharma Ad, Eufilinas
  • Latvia · Sophafyllin
  • Portugal · Aminofilina Labesfal, Filotempo
  • Romania · Aminofilină Arena, Aminofilina Bioeel
  • Sweden · Teofyllamin
  • Slovakia · Syntophyllin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/027e6aef-b0db-41f8-a2cc-3a4bb13eb9b1
GET /v1/drugs/027e6aef-b0db-41f8-a2cc-3a4bb13eb9b1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Injeksjonsvæske, oppløsning",
  "source": "fest",
  "status": "A",
  "atc_name": "Teofyllinetylendiamin",
  "merkevare_id": "ID_6DC557E8-59E5-4A05-83F2-7F4D3F25AC11",
  "name_form_strength": "Aminophylline hameln inj, oppl 25 mg/ml",
  "prescription_group": "C"
}
API referenceMCP serverPlans

See everything about aminophylline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console